| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-18 11:36 Tx date 2026-03-16 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$36,274
+453,429 vol $0.08 each |
6,544,062 | |
| Filed 2026-03-18 11:34 Tx date 2026-03-16 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,909
+136,368 vol $0.08 each |
866,976 | |
| Filed 2026-03-18 11:33 Tx date 2026-03-16 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$61,366
+767,079 vol $0.08 each |
5,827,258 | |
| Filed 2026-03-18 11:31 Tx date 2026-03-16 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$202,372
+2,529,653 vol $0.08 each |
17,718,518 | |
| Filed 2026-01-08 20:19 Tx date 2024-11-19 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+50,000 vol $0.10 each |
12,296,378 | |
| Filed 2026-01-08 20:18 Tx date 2024-11-18 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,460
+300,000 vol $0.0782 each |
12,246,378 | |
| Filed 2026-01-08 20:17 Tx date 2024-11-07 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,655
-43,000 vol $0.085 each |
11,896,378 | |
| Filed 2026-01-08 20:16 Tx date 2024-11-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,254.80
-297,000 vol $0.0884 each |
11,939,378 | |
| Filed 2026-01-08 20:15 Tx date 2024-11-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,232.40
-341,500 vol $0.0856 each |
12,236,378 | |
| Filed 2026-01-08 20:14 Tx date 2024-11-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,701.80
-217,000 vol $0.0954 each |
12,577,878 | |
| Filed 2026-01-08 20:14 Tx date 2024-10-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,465
-33,000 vol $0.105 each |
12,794,878 | |
| Filed 2026-01-08 20:13 Tx date 2024-10-30 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,844.80
-111,500 vol $0.1152 each |
12,827,878 | |
| Filed 2026-01-08 20:12 Tx date 2024-10-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,663.20
-62,000 vol $0.1236 each |
12,939,378 | |
| Filed 2026-01-08 20:11 Tx date 2024-10-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,500
+350,000 vol $0.13 each |
13,001,378 | |
| Filed 2026-01-08 20:10 Tx date 2024-10-24 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$69,860
+700,000 vol $0.0998 each |
12,651,378 | |
| Filed 2026-01-08 20:09 Tx date 2024-10-23 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,985
+150,000 vol $0.0999 each |
11,951,378 | |
| Filed 2026-01-08 20:08 Tx date 2024-10-22 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,617
+71,000 vol $0.0932 each |
11,801,378 | |
| Filed 2026-01-08 20:07 Tx date 2024-10-21 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,880
+400,000 vol $0.0997 each |
11,730,378 | |
| Filed 2026-01-08 20:06 Tx date 2024-10-18 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66,489
+605,000 vol $0.1099 each |
11,330,378 | |
| Filed 2026-01-08 20:05 Tx date 2024-04-26 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,980
-200,000 vol $0.1499 each |
10,023,676 | |
| Filed 2026-01-08 20:04 Tx date 2024-04-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,500
-150,000 vol $0.15 each |
10,223,676 | |
| Filed 2026-01-08 20:03 Tx date 2024-04-19 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,801.20
-318,500 vol $0.1752 each |
10,373,676 | |
| Filed 2026-01-08 20:02 Tx date 2024-04-16 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,545
-64,500 vol $0.21 each |
10,692,176 | |
| Filed 2026-01-08 20:01 Tx date 2024-04-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-56,175
-250,000 vol $0.2247 each |
10,756,676 | |
| Filed 2026-01-08 20:01 Tx date 2024-04-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,760
+200,000 vol $0.2488 each |
11,006,676 | |
| Filed 2026-01-08 20:00 Tx date 2024-04-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-104,000
-400,000 vol $0.26 each |
10,806,676 | |
| Filed 2026-01-08 19:59 Tx date 2024-04-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80,760
+300,000 vol $0.2692 each |
11,206,676 | |
| Filed 2026-01-08 19:58 Tx date 2024-04-03 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72,180
+300,000 vol $0.2406 each |
10,906,676 | |
| Filed 2026-01-08 19:57 Tx date 2024-04-02 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$138,187
+625,000 vol $0.2211 each |
10,606,676 | |
| Filed 2026-01-08 19:56 Tx date 2024-04-02 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-105,750
-450,000 vol $0.235 each |
9,981,676 | |
| Filed 2026-01-08 19:54 Tx date 2024-04-02 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,500
+100,000 vol $0.235 each |
10,431,676 | |
| Filed 2026-01-08 19:53 Tx date 2024-04-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,127
+75,000 vol $0.2017 each |
10,331,676 | |
| Filed 2026-01-08 19:51 Tx date 2024-03-28 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-147,400
-737,000 vol $0.20 each |
10,256,676 | |
| Filed 2026-01-08 19:50 Tx date 2024-03-28 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$108,350
+500,000 vol $0.2167 each |
10,993,676 | |
| Filed 2026-01-08 19:49 Tx date 2024-03-26 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,690
+50,000 vol $0.1938 each |
10,493,676 | |
| Filed 2026-01-08 19:49 Tx date 2024-03-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,625
+150,000 vol $0.1775 each |
10,443,676 | |
| Filed 2026-01-08 19:48 Tx date 2024-03-22 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,615
+275,000 vol $0.1586 each |
10,293,676 | |
| Filed 2026-01-08 19:46 Tx date 2024-03-21 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,696
+160,000 vol $0.1481 each |
10,018,676 | |
| Filed 2026-01-08 19:45 Tx date 2024-03-21 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,200
-8,000 vol $0.15 each |
9,858,676 | |
| Filed 2026-01-08 19:44 Tx date 2023-09-19 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,575
+10,000 vol $0.2575 each |
8,205,312 | |
| Filed 2026-01-08 19:43 Tx date 2023-09-18 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,604
+105,000 vol $0.2629 each |
8,195,312 | |
| Filed 2026-01-08 19:43 Tx date 2023-09-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$78,240
+300,000 vol $0.2608 each |
8,090,312 | |
| Filed 2026-01-08 19:41 Tx date 2023-09-14 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$59,256
+249,500 vol $0.2375 each |
7,790,312 | |
| Filed 2026-01-08 19:40 Tx date 2023-09-13 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,907
+175,000 vol $0.2109 each |
7,540,812 | |
| Filed 2026-01-08 19:40 Tx date 2023-09-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,408
+220,000 vol $0.2064 each |
7,365,812 | |
| Filed 2026-01-08 19:38 Tx date 2023-09-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,525
+175,000 vol $0.203 each |
7,145,812 | |
| Filed 2026-01-08 19:37 Tx date 2023-09-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,500
+50,000 vol $0.19 each |
6,970,812 | |
| Filed 2026-01-08 19:36 Tx date 2023-08-30 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,517
+75,000 vol $0.1669 each |
6,920,812 | |
| Filed 2026-01-08 19:36 Tx date 2023-08-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+40,000 vol $0.1625 each |
6,845,812 | |
| Filed 2026-01-08 19:35 Tx date 2023-08-24 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,480
+100,000 vol $0.1348 each |
6,805,812 | |
| Filed 2026-01-08 19:34 Tx date 2023-08-21 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,500
+100,000 vol $0.115 each |
6,705,812 | |
| Filed 2026-01-08 19:34 Tx date 2023-08-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,000
+100,000 vol $0.14 each |
6,605,812 | |
| Filed 2026-01-07 22:04 Tx date 2023-06-22 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,105.60
-42,000 vol $0.2168 each |
6,202,627 | |
| Filed 2026-01-07 22:03 Tx date 2023-06-21 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,015
-50,000 vol $0.2203 each |
6,244,627 | |
| Filed 2026-01-07 22:02 Tx date 2023-06-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$151,514
+710,000 vol $0.2134 each |
6,294,627 | |
| Filed 2026-01-07 22:00 Tx date 2023-06-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,662
+125,000 vol $0.2213 each |
5,584,627 | |
| Filed 2026-01-07 21:59 Tx date 2023-06-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+100,000 vol $0.21 each |
5,459,627 | |
| Filed 2026-01-07 21:59 Tx date 2023-06-02 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+50,000 vol $0.21 each |
5,359,627 | |
| Filed 2026-01-07 21:58 Tx date 2023-06-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,260
+200,000 vol $0.1863 each |
5,309,627 | |
| Filed 2026-01-07 21:57 Tx date 2023-05-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,750
+100,000 vol $0.1775 each |
5,109,627 | |
| Filed 2026-01-07 21:56 Tx date 2023-05-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+100,000 vol $0.20 each |
5,009,627 | |
| Filed 2026-01-07 21:55 Tx date 2023-05-24 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,840
+150,000 vol $0.2056 each |
4,909,627 | |
| Filed 2026-01-07 21:55 Tx date 2023-05-23 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+100,000 vol $0.20 each |
4,759,627 | |
| Filed 2026-01-07 21:54 Tx date 2023-05-19 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,750
+100,000 vol $0.1875 each |
4,659,627 | |
| Filed 2026-01-07 21:53 Tx date 2023-05-18 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,910
+100,000 vol $0.1891 each |
4,559,627 | |
| Filed 2026-01-07 21:52 Tx date 2023-05-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$73,000
+400,000 vol $0.1825 each |
4,459,627 | |
| Filed 2026-01-07 21:52 Tx date 2023-05-09 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,000
+100,000 vol $0.19 each |
4,059,627 | |
| Filed 2026-01-07 21:51 Tx date 2023-05-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,260
+200,000 vol $0.1963 each |
3,959,627 | |
| Filed 2026-01-07 21:50 Tx date 2023-05-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,875
+50,000 vol $0.1975 each |
3,759,627 | |
| Filed 2026-01-07 21:49 Tx date 2023-05-03 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+50,000 vol $0.20 each |
3,709,627 | |
| Filed 2026-01-07 21:48 Tx date 2023-05-02 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+50,000 vol $0.20 each |
3,659,627 | |
| Filed 2026-01-07 21:48 Tx date 2023-04-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$59,175
+250,000 vol $0.2367 each |
3,609,627 | |
| Filed 2026-01-07 21:46 Tx date 2023-04-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,000
+100,000 vol $0.26 each |
3,359,627 | |
| Filed 2026-01-07 21:46 Tx date 2023-04-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,000
+50,000 vol $0.26 each |
3,259,627 | |
| Filed 2026-01-07 21:45 Tx date 2023-04-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,500
+100,000 vol $0.255 each |
3,209,627 | |
| Filed 2026-01-07 21:45 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,500
+50,000 vol $0.23 each |
3,109,627 | |
| Filed 2026-01-07 21:44 Tx date 2023-03-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,500
+100,000 vol $0.235 each |
3,059,627 | |
| Filed 2026-01-07 21:43 Tx date 2023-03-28 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,130
+31,000 vol $0.23 each |
2,959,627 | |
| Filed 2026-01-07 21:43 Tx date 2023-03-27 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,625
+169,000 vol $0.2108 each |
2,928,627 | |
| Filed 2026-01-07 21:42 Tx date 2023-03-24 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,700
+18,500 vol $0.20 each |
2,759,627 | |
| Filed 2026-01-07 21:41 Tx date 2023-03-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+12,500 vol $0.20 each |
2,741,127 | |
| Filed 2026-01-07 21:40 Tx date 2023-03-16 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,650
+100,000 vol $0.2065 each |
2,728,627 | |
| Filed 2026-01-07 21:40 Tx date 2023-03-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,850
+100,000 vol $0.1885 each |
2,628,627 | |
| Filed 2026-01-07 21:38 Tx date 2023-03-14 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,680
+50,000 vol $0.1936 each |
2,528,627 | |
| Filed 2026-01-07 21:38 Tx date 2023-03-03 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,000
+100,000 vol $0.24 each |
2,478,627 | |
| Filed 2026-01-07 21:37 Tx date 2023-02-16 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,000
+100,000 vol $0.27 each |
2,378,627 | |
| Filed 2026-01-07 21:36 Tx date 2023-02-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+100,000 vol $0.275 each |
2,278,627 | |
| Filed 2026-01-07 21:36 Tx date 2023-01-26 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,000
+100,000 vol $0.25 each |
2,178,627 | |
| Filed 2026-01-07 21:35 Tx date 2023-01-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,750
+50,000 vol $0.235 each |
2,078,627 | |
| Filed 2026-01-07 21:34 Tx date 2023-01-23 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,675
+25,000 vol $0.307 each |
2,028,627 | |
| Filed 2026-01-07 21:33 Tx date 2023-01-18 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,790
+50,000 vol $0.2958 each |
2,003,627 | |
| Filed 2026-01-07 21:33 Tx date 2023-01-17 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,667
+25,000 vol $0.3867 each |
1,953,627 | |
| Filed 2026-01-07 21:32 Tx date 2023-01-16 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,980
+75,000 vol $0.3864 each |
1,928,627 | |
| Filed 2026-01-07 21:31 Tx date 2023-01-13 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,000
+100,000 vol $0.33 each |
1,853,627 | |
| Filed 2026-01-07 21:30 Tx date 2023-01-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,350
+100,000 vol $0.3735 each |
1,753,627 | |
| Filed 2026-01-07 21:30 Tx date 2023-01-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,200
+45,000 vol $0.36 each |
1,553,627 | |
| Filed 2026-01-07 21:28 Tx date 2023-01-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,475
+125,000 vol $0.3398 each |
1,508,627 | |
| Filed 2026-01-07 21:27 Tx date 2023-01-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,370
+150,000 vol $0.2358 each |
1,258,627 | |
| Filed 2026-01-07 21:26 Tx date 2022-04-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,950
+8,500 vol $0.70 each |
775,000 | |
| Filed 2026-01-07 21:25 Tx date 2022-04-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,049
+41,500 vol $0.70 each |
766,500 | |
| Filed 2026-01-07 21:24 Tx date 2022-04-07 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,935
+50,000 vol $0.70 each |
725,000 | |
| Filed 2026-01-07 21:24 Tx date 2022-04-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,000
+50,000 vol $0.70 each |
675,000 | |
| Filed 2026-01-07 21:23 Tx date 2022-03-30 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,000
+100,000 vol $0.70 each |
625,000 | |
| Filed 2026-01-07 21:22 Tx date 2022-03-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$92,175
+125,000 vol $0.74 each |
525,000 | |
| Filed 2026-01-07 21:22 Tx date 2022-03-14 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$210,000
+300,000 vol $0.70 each |
400,000 | |
| Filed 2026-01-07 21:21 Tx date 2022-03-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$81,500
+100,000 vol $0.81 each |
100,000 | |
| Filed 2025-12-30 21:28 Tx date 2023-08-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+14,000 vol $0.1143 each |
5,381,809 | |
| Filed 2025-12-30 21:26 Tx date 2023-08-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,500
+50,000 vol $0.15 each |
5,367,809 | |
| Filed 2025-12-30 21:25 Tx date 2023-08-21 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,990
+300,000 vol $0.1133 each |
5,317,809 | |
| Filed 2025-10-22 11:18 Tx date 2022-11-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,400
+50,000 vol $0.388 each |
66,651 | |
| Filed 2025-10-22 11:18 Tx date 2023-06-30 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+10,000 vol $0.20 each |
861,812 | |
| Filed 2025-10-22 11:16 Tx date 2023-10-17 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,448
+217,000 vol $0.2417 each |
1,078,812 | |
| Filed 2025-10-22 11:16 Tx date 2023-10-18 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,566
+133,000 vol $0.2599 each |
1,211,812 | |
| Filed 2025-10-22 11:15 Tx date 2023-11-19 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,300
+125,000 vol $0.2664 each |
1,356,812 | |
| Filed 2025-10-22 11:13 Tx date 2023-11-02 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,700
+40,000 vol $0.1925 each |
1,251,812 | |
| Filed 2025-10-22 11:12 Tx date 2023-11-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,800
+20,000 vol $0.19 each |
1,231,812 | |
| Filed 2025-10-22 11:11 Tx date 2023-11-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,200
-40,000 vol $0.18 each |
1,211,812 | |
| Filed 2025-10-22 11:10 Tx date 2023-11-21 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,700
-30,000 vol $0.19 each |
1,346,812 | |
| Filed 2025-10-22 11:10 Tx date 2023-11-21 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,900
+20,000 vol $0.195 each |
1,376,812 | |
| Filed 2025-10-22 11:09 Tx date 2023-11-22 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,600
-73,000 vol $0.20 each |
1,326,812 | |
| Filed 2025-10-22 11:08 Tx date 2023-11-22 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,165
+50,000 vol $0.2033 each |
1,399,812 | |
| Filed 2025-10-22 11:07 Tx date 2023-11-22 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-410.00
-2,000 vol $0.205 each |
1,349,812 | |
| Filed 2025-10-22 11:06 Tx date 2023-11-22 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,050
+5,000 vol $0.21 each |
1,351,812 | |
| Filed 2025-10-22 11:05 Tx date 2024-02-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,690
+50,000 vol $0.1738 each |
1,878,176 | |
| Filed 2025-10-22 11:04 Tx date 2024-02-07 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,858
+70,000 vol $0.1694 each |
1,948,176 | |
| Filed 2025-10-22 11:04 Tx date 2024-02-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,458
+60,000 vol $0.1743 each |
2,008,176 | |
| Filed 2025-10-22 11:03 Tx date 2024-02-13 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,250
+50,000 vol $0.185 each |
2,058,176 | |
| Filed 2025-10-22 11:02 Tx date 2024-02-14 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,625
+25,000 vol $0.185 each |
2,083,176 | |
| Filed 2025-10-22 11:02 Tx date 2024-02-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,812
+125,000 vol $0.1985 each |
2,208,176 | |
| Filed 2025-10-22 11:01 Tx date 2024-02-21 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,415
+35,000 vol $0.1833 each |
2,243,176 | |
| Filed 2025-10-22 11:00 Tx date 2024-02-22 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,850
+10,000 vol $0.185 each |
2,253,176 | |
| Filed 2025-10-22 10:59 Tx date 2024-02-23 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,300
+35,000 vol $0.18 each |
1,338,176 | |
| Filed 2025-10-22 10:58 Tx date 2024-02-26 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,275
+75,000 vol $0.177 each |
1,413,176 | |
| Filed 2025-10-22 10:58 Tx date 2024-02-28 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,900
+100,000 vol $0.169 each |
1,513,176 | |
| Filed 2025-10-22 10:57 Tx date 2024-02-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,500
+50,000 vol $0.17 each |
1,563,176 | |
| Filed 2025-10-22 10:56 Tx date 2024-03-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+10,000 vol $0.16 each |
1,573,176 | |
| Filed 2025-10-22 10:55 Tx date 2024-09-13 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,875
+75,000 vol $0.105 each |
1,648,176 | |
| Filed 2025-10-22 10:45 Tx date 2024-09-16 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,625
+75,000 vol $0.115 each |
1,723,176 | |
| Filed 2025-10-22 10:44 Tx date 2024-09-26 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,040
-544,000 vol $0.16 each |
1,291,976 | |
| Filed 2025-10-22 10:44 Tx date 2024-09-26 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,623
+112,800 vol $0.1651 each |
1,835,976 | |
| Filed 2025-10-22 10:43 Tx date 2024-11-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,250
+50,000 vol $0.085 each |
2,324,878 | |
| Filed 2025-10-22 10:42 Tx date 2024-11-26 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,280
+200,000 vol $0.0764 each |
2,524,878 | |
| Filed 2025-10-22 10:41 Tx date 2024-11-28 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,110
+90,000 vol $0.079 each |
2,614,878 | |
| Filed 2025-10-22 10:40 Tx date 2024-12-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,085
+150,000 vol $0.0939 each |
2,764,878 | |
| Filed 2025-10-22 10:39 Tx date 2024-12-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,750
+25,000 vol $0.11 each |
2,789,878 | |
| Filed 2025-10-22 10:38 Tx date 2024-12-16 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,150
+30,000 vol $0.105 each |
2,819,878 | |
| Filed 2025-10-22 10:37 Tx date 2025-05-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,350
+300,000 vol $0.0545 each |
4,967,365 | |
| Filed 2025-10-22 10:36 Tx date 2025-05-07 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,830
+100,000 vol $0.0583 each |
5,067,365 | |
| Filed 2025-10-22 10:35 Tx date 2025-05-30 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+100,000 vol $0.045 each |
5,167,365 | |
| Filed 2025-10-22 10:34 Tx date 2025-06-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,750
+50,000 vol $0.055 each |
5,217,365 | |
| Filed 2025-10-22 10:32 Tx date 2022-11-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$41,580
+100,000 vol $0.4158 each |
3,767,485 | |
| Filed 2025-10-22 10:31 Tx date 2022-11-14 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,565
+50,000 vol $0.4313 each |
3,817,485 | |
| Filed 2025-10-22 10:30 Tx date 2022-12-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,240
+80,000 vol $0.253 each |
4,047,485 | |
| Filed 2025-10-22 10:29 Tx date 2022-12-23 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$173,291
+845,324 vol $0.205 each |
4,892,809 | |
| Filed 2025-02-26 15:55 Tx date 2025-02-25 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+115,108 vol |
730,608 | |
| Filed 2025-02-26 15:55 Tx date 2025-02-25 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Debentures
57 - Exercise of rights
|
-$115,108 vol |
$84,892 | |
| Filed 2025-02-26 11:28 Tx date 2025-02-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Debentures
57 - Exercise of rights
|
-$1,847,487 vol |
$257,513 | |
| Filed 2025-02-26 11:28 Tx date 2025-02-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+1,847,487 vol |
4,133,565 | |
| Filed 2025-02-26 11:27 Tx date 2025-02-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+382,736 vol |
4,651,309 | |
| Filed 2025-02-26 11:26 Tx date 2025-02-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Debentures
57 - Exercise of rights
|
-$382,736 vol |
$522,264 | |
| Filed 2025-02-26 11:25 Tx date 2025-02-25 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+647,485 vol |
5,060,179 | |
| Filed 2025-02-26 11:25 Tx date 2025-02-25 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
57 - Exercise of rights
|
-$647,485 vol |
$477,515 | |
| Filed 2024-10-11 19:41 Tx date 2024-10-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+392,934 vol |
4,412,694 | |
| Filed 2024-10-11 19:38 Tx date 2024-10-07 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+633,626 vol |
2,286,078 | |
| Filed 2024-10-11 19:37 Tx date 2024-10-07 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+349,276 vol |
1,652,452 | |
| Filed 2024-10-11 19:35 Tx date 2024-10-07 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+230,511 vol |
4,268,573 | |
| Filed 2024-10-11 08:42 Tx date 2024-10-07 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+69,854 vol |
615,500 | |
| Filed 2024-07-15 20:27 Tx date 2024-07-12 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$100,000 vol |
$100,000 | |
| Filed 2024-07-15 20:27 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-07-15 20:25 Tx date 2024-07-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$600,000 vol |
$905,000 | |
| Filed 2024-04-16 16:04 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
828,290 | |
| Filed 2024-04-16 16:03 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2024-04-16 16:03 Tx date 2019-07-22 |
$PCLO
PharmaCielo Ltd. |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 16:00 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+750,000 vol |
750,000 | |
| Filed 2024-04-16 15:59 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 15:59 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+125,000 vol |
125,000 | |
| Filed 2024-04-16 15:58 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
535,000 | |
| Filed 2024-04-16 15:56 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+125,000 vol |
125,000 | |
| Filed 2024-04-16 15:55 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+266,119 vol |
266,119 | |
| Filed 2024-04-16 15:55 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 15:54 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
2,152,900 | |
| Filed 2024-04-16 15:53 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+529,829 vol |
529,829 | |
| Filed 2024-04-16 15:52 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 15:31 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,098,300 | |
| Filed 2024-04-16 15:30 Tx date 2024-04-11 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+300,000 vol |
300,000 | |
| Filed 2024-04-16 15:29 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-17 11:23 Tx date 2024-01-17 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,642.6538
-57,298 vol $0.2381 each |
545,646 | |
| Filed 2024-01-16 12:06 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+78,737 vol |
||
| Filed 2024-01-16 12:06 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+466,504 vol |
||
| Filed 2024-01-16 12:03 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+340,751 vol |
||
| Filed 2023-04-05 10:39 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+466,504 vol |
||
| Filed 2023-04-05 10:34 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+340,751 vol |
||
| Filed 2023-04-05 10:26 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+78,737 vol |
||
| Filed 2024-01-10 12:50 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$96,512
+501,364 vol $0.1925 each |
1,303,176 | |
| Filed 2024-01-10 12:49 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$18,398
+95,577 vol $0.1925 each |
4,504,566 | |
| Filed 2024-01-10 12:48 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$62,044
+322,308 vol $0.1925 each |
4,098,497 | |
| Filed 2024-01-10 12:47 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$11,029
+57,298 vol $0.1925 each |
602,944 | |
| Filed 2024-01-09 21:24 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$25,000 vol |
$2,105,000 | |
| Filed 2024-01-09 21:24 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+25,000 vol |
957,500 | |
| Filed 2024-01-09 21:23 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+115,000 vol |
162,500 | |
| Filed 2024-01-09 21:20 Tx date 2024-01-08 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$115,000 vol |
$305,000 | |
| Filed 2023-10-20 19:55 Tx date 2023-08-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$550,000 vol |
$2,080,000 | |
| Filed 2023-07-21 11:24 Tx date 2023-07-19 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,030,576 vol |
3,776,189 | |
| Filed 2023-07-21 11:23 Tx date 2023-07-19 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,030,576 vol |
0 | |
| Filed 2023-06-30 10:01 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,969
+55,040 vol $0.1993 each |
545,646 | |
| Filed 2023-06-30 10:00 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$61,705
+309,609 vol $0.1993 each |
1,745,613 | |
| Filed 2023-06-30 09:59 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,808
+9,072 vol $0.1993 each |
801,812 | |
| Filed 2023-06-30 09:59 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,787
+13,987 vol $0.1993 each |
792,740 | |
| Filed 2023-06-30 09:58 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$759.33
+3,810 vol $0.1993 each |
778,753 | |
| Filed 2023-06-30 09:58 Tx date 2023-06-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$53,076
+266,316 vol $0.1993 each |
774,943 | |
| Filed 2023-06-12 15:56 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$80,000
+166,667 vol $0.48 each |
1,436,004 | |
| Filed 2023-06-12 15:56 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-80,000.16
-166,667 vol $0.48 each |
2,030,576 | |
| Filed 2023-06-12 15:50 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$250,000 vol |
$1,530,000 | |
| Filed 2023-06-12 15:50 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$500,000 vol |
$1,280,000 | |
| Filed 2023-06-12 15:48 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+62,500 vol |
382,500 | |
| Filed 2023-06-12 15:47 Tx date 2023-06-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+125,000 vol |
320,000 | |
| Filed 2023-04-05 10:39 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+466,504 vol |
4,408,989 | |
| Filed 2023-04-05 10:37 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+466,504 vol |
||
| Filed 2023-04-05 10:36 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+466,504 vol |
||
| Filed 2023-04-05 10:34 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+340,751 vol |
410,751 | |
| Filed 2023-04-05 10:34 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
410,000 | |
| Filed 2023-04-05 10:28 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
798,300 | |
| Filed 2023-04-05 10:26 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+78,737 vol |
1,269,337 | |
| Filed 2023-04-05 10:25 Tx date 2023-03-31 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
2,027,900 | |
| Filed 2023-01-18 22:33 Tx date 2023-01-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,045
+50,000 vol $0.3809 each |
508,627 | |
| Filed 2023-01-18 22:32 Tx date 2023-01-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,740
+25,000 vol $0.3896 each |
458,627 | |
| Filed 2023-01-18 22:31 Tx date 2023-01-12 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,750
+25,000 vol $0.35 each |
433,627 | |
| Filed 2023-01-16 11:00 Tx date 2023-01-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,400
+25,000 vol $0.336 each |
408,627 | |
| Filed 2023-01-16 11:00 Tx date 2023-01-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,495
+50,000 vol $0.3499 each |
383,627 | |
| Filed 2023-01-16 10:59 Tx date 2023-01-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,545
+25,000 vol $0.3418 each |
333,627 | |
| Filed 2023-01-16 10:59 Tx date 2023-01-10 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,290
+25,000 vol $0.3316 each |
308,627 | |
| Filed 2023-01-12 12:44 Tx date 2023-01-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,500
+25,000 vol $0.30 each |
3,942,485 | |
| Filed 2023-01-12 12:43 Tx date 2023-01-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,930
+50,000 vol $0.2786 each |
3,917,485 | |
| Filed 2023-01-12 12:43 Tx date 2023-01-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,790
+50,000 vol $0.2958 each |
3,867,485 | |
| Filed 2023-01-11 11:47 Tx date 2023-01-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,435
+50,000 vol $0.2487 each |
283,627 | |
| Filed 2023-01-11 11:46 Tx date 2023-01-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,435
+50,000 vol $0.2287 each |
233,627 | |
| Filed 2023-01-11 11:46 Tx date 2023-01-05 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,500
+50,000 vol $0.23 each |
183,627 | |
| Filed 2023-01-05 13:42 Tx date 2022-12-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+5,000 vol |
195,000 | |
| Filed 2023-01-05 13:40 Tx date 2022-12-31 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$20,000 vol |
$780,000 | |
| Filed 2022-12-16 13:57 Tx date 2022-12-15 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+52,587 vol |
1,190,600 | |
| Filed 2022-12-16 13:56 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+52,587 vol |
||
| Filed 2022-12-16 13:54 Tx date 2022-12-15 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+66,976 vol |
133,627 | |
| Filed 2022-12-16 13:54 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+66,976 vol |
||
| Filed 2022-12-16 13:48 Tx date 2022-12-15 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+19,933 vol |
490,606 | |
| Filed 2022-12-16 13:48 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+19,933 vol |
||
| Filed 2022-12-15 13:33 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+52,587 vol |
||
| Filed 2022-12-15 13:18 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+66,976 vol |
||
| Filed 2022-12-15 13:15 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+19,933 vol |
||
| Filed 2022-12-15 13:43 Tx date 2022-09-14 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
250,000 | |
| Filed 2022-12-15 13:42 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-15 13:41 Tx date 2022-09-14 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Restricted Share Units
57 - Exercise of rights
|
-250,000 vol |
0 | |
| Filed 2022-12-15 13:36 Tx date 2022-12-02 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+117,500 vol |
281,250 | |
| Filed 2022-12-15 13:34 Tx date 2022-11-14 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$470,000 vol |
$1,125,000 | |
| Filed 2022-12-15 13:33 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+52,587 vol |
1,190,600 | |
| Filed 2022-12-15 13:29 Tx date 2022-12-02 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+50,000 vol |
190,000 | |
| Filed 2022-12-15 13:24 Tx date 2022-11-04 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$200,000 vol |
$760,000 | |
| Filed 2022-12-15 13:18 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+66,976 vol |
133,627 | |
| Filed 2022-12-15 13:15 Tx date 2022-12-01 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+19,933 vol |
490,606 | |
| Filed 2022-11-30 09:28 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,800
+45,000 vol $0.44 each |
3,817,485 | |
| Filed 2022-11-30 09:28 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,740
+4,000 vol $0.435 each |
3,772,485 | |
| Filed 2022-11-30 09:27 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,910
+85,500 vol $0.42 each |
3,768,485 | |
| Filed 2022-11-30 09:26 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,867
+4,500 vol $0.415 each |
3,682,985 | |
| Filed 2022-11-30 09:26 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$410.00
+1,000 vol $0.41 each |
3,678,485 | |
| Filed 2022-11-30 09:25 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+10,000 vol $0.40 each |
3,677,485 | |
| Filed 2022-11-30 09:24 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+20,000 vol $0.40 each |
66,651 | |
| Filed 2022-11-30 09:23 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,700
+15,000 vol $0.38 each |
46,651 | |
| Filed 2022-11-30 09:23 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,290
+11,000 vol $0.39 each |
31,651 | |
| Filed 2022-11-30 09:22 Tx date 2022-11-25 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,540
+4,000 vol $0.385 each |
20,651 | |
| Filed 2022-11-22 21:00 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$455,000 vol |
$655,000 | |
| Filed 2022-11-22 20:58 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+113,750 vol |
163,750 | |
| Filed 2022-11-22 19:54 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+113,750 vol |
163,750 | |
| Filed 2022-11-22 19:54 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+113,750 vol |
||
| Filed 2022-11-22 19:51 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$455,000 vol |
||
| Filed 2022-11-22 19:51 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$455,000 vol |
$655,000 | |
| Filed 2022-11-22 19:43 Tx date 2022-10-14 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$430,000 vol |
$560,000 | |
| Filed 2022-11-22 19:41 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+107,500 vol |
140,000 | |
| Filed 2022-11-22 19:35 Tx date 2022-10-14 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$430,000 vol |
||
| Filed 2022-11-22 19:20 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$455,000 vol $1,000 each |
||
| Filed 2022-11-22 19:20 Tx date 2022-10-18 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$455,000 vol $1,000 each |
||
| Filed 2022-11-22 19:10 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+113,750 vol |
||
| Filed 2022-11-22 19:10 Tx date 2022-11-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+113,750 vol |
||
| Filed 2022-10-28 19:53 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+278,290 vol |
578,290 | |
| Filed 2022-10-17 15:04 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+907,900 vol |
1,427,900 | |
| Filed 2022-10-17 15:03 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+923,910 vol |
2,197,243 | |
| Filed 2022-10-17 15:03 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+940,000 vol |
1,273,333 | |
| Filed 2022-10-17 15:01 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
590,000 | |
| Filed 2022-10-17 15:00 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
3,110,000 | |
| Filed 2022-10-17 14:59 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
210,000 | |
| Filed 2022-10-17 14:56 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+448,300 vol |
448,300 | |
| Filed 2022-10-17 14:56 Tx date 2022-10-06 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+530,000 vol |
530,000 | |
| Filed 2022-10-11 13:04 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
| Filed 2022-10-11 13:01 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
| Filed 2022-10-11 12:55 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+448,300 vol |
||
| Filed 2022-10-11 12:52 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+530,000 vol |
||
| Filed 2022-10-11 12:32 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+923,910 vol |
||
| Filed 2022-10-11 12:24 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+940,000 vol |
||
| Filed 2022-10-11 12:17 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
| Filed 2022-10-11 12:13 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+907,900 vol |
||
| Filed 2022-10-11 15:44 Tx date 2022-09-30 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+25,000 vol |
50,000 | |
| Filed 2022-10-11 15:38 Tx date 2022-09-30 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+5,000 vol |
32,500 | |
| Filed 2022-10-11 15:37 Tx date 2022-09-01 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
53 - Grant of warrants
|
+27,500 vol |
27,500 | |
| Filed 2022-10-11 14:30 Tx date 2022-09-30 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$100,000 vol |
$200,000 | |
| Filed 2022-10-11 14:19 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-11 14:17 Tx date 2022-09-30 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$20,000 vol |
$130,000 | |
| Filed 2022-10-11 14:16 Tx date 2022-05-13 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$110,000 vol |
$110,000 | |
| Filed 2022-10-11 14:11 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-11 13:04 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
590,000 | |
| Filed 2022-10-11 13:01 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
210,000 | |
| Filed 2022-10-11 12:55 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+448,300 vol |
448,300 | |
| Filed 2022-10-11 12:53 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-11 12:52 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+530,000 vol |
530,000 | |
| Filed 2022-10-11 12:32 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+923,910 vol |
2,197,243 | |
| Filed 2022-10-11 12:24 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+940,000 vol |
1,273,333 | |
| Filed 2022-10-11 12:20 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
| Filed 2022-10-11 12:18 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
||
| Filed 2022-10-11 12:17 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
3,110,000 | |
| Filed 2022-10-11 12:13 Tx date 2022-08-29 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+907,900 vol |
1,427,900 | |
| Filed 2022-10-11 09:47 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2022-10-11 09:47 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. |
Nicholas, William C.
4 - Director of Issuer
Holder: Inga Hrefna Nicholas (Control or Direction)
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-17 12:26 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
||
| Filed 2022-08-08 12:51 Tx date 2022-08-08 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,750
+25,000 vol $0.59 each |
1,138,013 | |
| Filed 2022-07-11 10:54 Tx date 2022-07-08 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,000
+50,000 vol $0.44 each |
1,113,013 | |
| Filed 2022-07-11 10:52 Tx date 2022-07-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,825
+88,500 vol $0.45 each |
1,063,013 | |
| Filed 2022-07-11 10:52 Tx date 2022-07-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,567
+3,500 vol $0.4479 each |
974,513 | |
| Filed 2022-07-11 10:52 Tx date 2022-07-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,535
+3,500 vol $0.4386 each |
971,013 | |
| Filed 2022-07-11 10:51 Tx date 2022-07-07 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,845
+4,500 vol $0.41 each |
967,513 | |
| Filed 2022-06-23 22:24 Tx date 2022-06-20 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$80,000
+166,667 vol $0.48 each |
962,013 | |
| Filed 2022-06-23 22:24 Tx date 2022-06-20 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-166,667 vol |
333,333 | |
| Filed 2022-06-23 22:22 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2021-09-17 12:30 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-22 14:13 Tx date 2022-06-21 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$340.00
+1,000 vol $0.34 each |
796,346 | |
| Filed 2022-06-20 14:28 Tx date 2022-06-17 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$622.50
+1,500 vol $0.415 each |
795,346 | |
| Filed 2022-06-20 14:28 Tx date 2022-06-17 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$205.00
+500 vol $0.41 each |
793,846 | |
| Filed 2022-06-10 12:03 Tx date 2022-06-09 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,332
+16,651 vol $0.56 each |
16,651 | |
| Filed 2022-06-10 12:02 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-10 11:59 Tx date 2022-06-09 |
$PCLO
PharmaCielo Ltd. |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,161
+16,346 vol $0.56 each |
793,346 | |
| Filed 2022-06-10 11:58 Tx date 2022-06-09 |
$PCLO
PharmaCielo Ltd. |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,580
+8,173 vol $0.56 each |
470,673 | |
| Filed 2022-04-11 11:07 Tx date 2022-04-08 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,049
+41,500 vol $0.70 each |
3,667,485 | |
| Filed 2022-04-05 10:05 Tx date 2022-04-04 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,000
+50,000 vol $0.70 each |
3,625,985 | |
| Filed 2022-04-05 09:26 Tx date 2022-04-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+750,000 vol |
777,000 | |
| Filed 2022-04-05 09:26 Tx date 2022-04-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-750,000 vol |
0 | |
| Filed 2022-04-05 09:24 Tx date 2022-04-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+375,000 vol |
462,500 | |
| Filed 2022-04-05 09:24 Tx date 2022-04-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-375,000 vol |
0 | |
| Filed 2022-03-31 12:54 Tx date 2022-03-30 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,000
+100,000 vol $0.70 each |
3,575,985 | |
| Filed 2022-03-28 13:10 Tx date 2022-03-25 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$91,975
+125,000 vol $0.74 each |
3,475,985 | |
| Filed 2022-03-14 18:12 Tx date 2022-03-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$210,000
+300,000 vol $0.70 each |
3,350,985 | |
| Filed 2022-03-14 18:11 Tx date 2022-03-11 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$81,500
+100,000 vol $0.81 each |
3,050,985 | |
| Filed 2022-03-04 08:53 Tx date 2022-03-03 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,160
+7,000 vol $0.88 each |
27,000 | |
| Filed 2021-12-31 18:02 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$200,000 vol $1,000 each |
$200,000 | |
| Filed 2021-12-31 18:00 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+50,000 vol |
50,000 | |
| Filed 2021-12-31 18:00 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-31 17:59 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$200,000 vol $1,000 each |
||
| Filed 2021-12-31 17:59 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$200,000 vol $1,000 each |
$200,000 | |
| Filed 2021-12-31 17:59 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-31 17:55 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+47,500 vol |
47,500 | |
| Filed 2021-12-31 17:54 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-31 17:53 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$190,000 vol $1,000 each |
$190,000 | |
| Filed 2021-12-31 17:53 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-31 17:51 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+25,000 vol |
25,000 | |
| Filed 2021-12-31 17:50 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-31 17:50 Tx date 2021-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $1,000 each |
$100,000 | |
| Filed 2021-12-31 17:49 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-08 12:46 Tx date 2021-11-05 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,125
+7,500 vol $0.95 each |
87,500 | |
| Filed 2021-11-03 11:40 Tx date 2021-11-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,182
+4,100 vol $1.02 each |
80,000 | |
| Filed 2021-10-30 18:54 Tx date 2021-10-29 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,018
+5,900 vol $1.02 each |
75,900 | |
| Filed 2021-10-28 09:34 Tx date 2021-10-27 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,200
+20,000 vol $1.06 each |
20,000 | |
| Filed 2021-10-28 09:33 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-27 14:17 Tx date 2021-10-27 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,400
+10,000 vol $1.04 each |
70,000 | |
| Filed 2021-10-25 18:04 Tx date 2021-10-22 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+10,000 vol $1.05 each |
60,000 | |
| Filed 2021-10-25 18:03 Tx date 2021-10-21 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,800
+20,000 vol $1.09 each |
50,000 | |
| Filed 2021-09-21 18:54 Tx date 2021-09-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,840
+14,400 vol $1.10 each |
30,000 | |
| Filed 2021-09-17 15:41 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+375,000 vol |
375,000 | |
| Filed 2021-09-17 15:39 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-17 12:31 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+750,000 vol |
750,000 | |
| Filed 2021-09-17 12:30 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-17 12:26 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2021-09-17 12:25 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-17 12:25 Tx date 2021-09-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2021-09-17 12:23 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Nicholas, William C.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-10 10:50 Tx date 2021-08-24 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,119,999
+1,333,333 vol $0.84 each |
1,333,333 | |
| Filed 2021-09-10 10:49 Tx date 2021-08-24 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,119,999.72
-1,333,333 vol $0.84 each |
666,667 | |
| Filed 2021-09-09 15:18 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
DeGabrielle, Robert Ronald
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-09 15:18 Tx date 2021-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
DeGabrielle, Robert Ronald
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-07 07:23 Tx date 2021-09-03 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,779,417
+1,617,652 vol $1.10 each |
1,617,652 | |
| Filed 2021-09-07 07:22 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-13 18:29 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
520,000 | ||
| Filed 2021-08-13 18:28 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-13 18:27 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Petron, William Boris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-13 15:37 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
1,945,000 | |
| Filed 2021-08-13 15:36 Tx date 2020-12-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
1,925,000 | |
| Filed 2021-08-13 15:34 Tx date 2020-05-04 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,500,000 vol |
1,725,000 | |
| Filed 2021-08-12 21:24 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
295,000 | |
| Filed 2021-08-12 21:23 Tx date 2021-05-13 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
275,000 | |
| Filed 2021-08-12 21:20 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
3,020,000 | |
| Filed 2021-08-12 21:16 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
120,000 | |
| Filed 2021-08-12 21:15 Tx date 2021-05-13 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2021-08-12 21:14 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-12 21:09 Tx date 2021-06-10 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
70,000 | |
| Filed 2021-08-12 21:08 Tx date 2021-05-13 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2021-08-12 21:07 Tx date 2019-08-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-19 08:56 Tx date 2021-07-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,439
+5,600 vol $1.15 each |
15,600 | |
| Filed 2021-06-11 15:05 Tx date 2021-06-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Atacan, Ian D
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2021-04-08 12:33 Tx date 2021-04-07 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,000
+23,256 vol $2.15 each |
204,367 | |
| Filed 2021-04-08 12:31 Tx date 2020-12-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,004
+27,000 vol $1.33 each |
181,111 | |
| Filed 2021-04-08 12:29 Tx date 2020-07-03 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$32,400
+45,000 vol $0.72 each |
154,111 | |
| Filed 2021-02-17 15:01 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2021-02-17 15:01 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,000,000 | ||
| Filed 2020-12-17 19:11 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,110
-500 vol $2.22 each |
0 | |
| Filed 2020-12-17 19:11 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,133
-7,300 vol $2.21 each |
500 | |
| Filed 2020-12-17 19:10 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,825
-1,700 vol $2.25 each |
7,800 | |
| Filed 2020-12-17 19:08 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-450.00
-200 vol $2.25 each |
9,500 | |
| Filed 2020-12-17 19:08 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-227.00
-100 vol $2.27 each |
9,700 | |
| Filed 2020-12-17 19:07 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-225.00
-100 vol $2.25 each |
9,800 | |
| Filed 2020-12-17 19:07 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-227.00
-100 vol $2.27 each |
9,900 | |
| Filed 2020-12-17 19:05 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,400
-5,000 vol $1.88 each |
10,000 | |
| Filed 2020-12-17 19:04 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,050
-5,000 vol $1.81 each |
15,000 | |
| Filed 2020-12-17 19:03 Tx date 2020-12-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,050
-5,000 vol $1.81 each |
20,000 | |
| Filed 2020-12-17 19:02 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,600
-5,000 vol $1.72 each |
25,000 | |
| Filed 2020-12-17 19:02 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,350
-5,000 vol $1.67 each |
30,000 | |
| Filed 2020-12-17 19:01 Tx date 2020-12-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,300
-5,000 vol $1.46 each |
35,000 | |
| Filed 2020-12-17 19:01 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,250
-5,000 vol $1.45 each |
40,000 | |
| Filed 2020-12-17 19:00 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
45,000 | |
| Filed 2020-12-17 19:00 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
||
| Filed 2020-12-17 19:00 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,620
-8,500 vol $1.72 each |
||
| Filed 2020-12-17 18:59 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,350
-5,000 vol $1.67 each |
||
| Filed 2020-12-17 18:59 Tx date 2020-12-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,600
-10,000 vol $1.46 each |
||
| Filed 2020-12-17 18:59 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,500
-10,000 vol $1.45 each |
||
| Filed 2020-12-17 18:59 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
||
| Filed 2020-12-17 17:55 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,620
-8,500 vol $1.72 each |
6,500 | |
| Filed 2020-12-17 17:55 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,620
-8,500 vol $1.72 each |
||
| Filed 2020-12-17 17:54 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,350
-5,000 vol $1.67 each |
15,000 | |
| Filed 2020-12-17 17:54 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,350
-5,000 vol $1.67 each |
||
| Filed 2020-12-17 17:36 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,200
-10,000 vol $1.72 each |
||
| Filed 2020-12-17 17:36 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,200
-10,000 vol $1.72 each |
||
| Filed 2020-12-17 17:35 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,700
-10,000 vol $1.67 each |
||
| Filed 2020-12-17 17:35 Tx date 2020-12-16 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,700
-10,000 vol $1.67 each |
||
| Filed 2020-12-17 17:33 Tx date 2020-12-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,600
-10,000 vol $1.46 each |
||
| Filed 2020-12-17 17:33 Tx date 2020-12-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,600
-10,000 vol $1.46 each |
20,000 | |
| Filed 2020-12-17 17:31 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,500
-10,000 vol $1.45 each |
30,000 | |
| Filed 2020-12-17 17:31 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,500
-10,000 vol $1.45 each |
||
| Filed 2020-12-17 17:30 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
||
| Filed 2020-12-17 17:30 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
40,000 | |
| Filed 2020-12-17 17:25 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
45,000 | |
| Filed 2020-12-17 17:25 Tx date 2020-12-14 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,900
-5,000 vol $1.38 each |
||
| Filed 2020-11-23 09:55 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+25,000 vol |
25,000 | |
| Filed 2020-11-23 09:54 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-23 09:53 Tx date 2020-11-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+50,000 vol $0.50 each |
70,000 | |
| Filed 2020-06-02 11:34 Tx date 2020-05-27 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
275,000 | |
| Filed 2020-06-02 11:32 Tx date 2020-05-27 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-125,000 vol |
125,000 | |
| Filed 2020-05-28 15:02 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+109,111 vol |
109,111 | |
| Filed 2020-05-28 14:58 Tx date 2019-08-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-28 14:51 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-109,111 vol |
0 | |
| Filed 2020-05-28 14:50 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$70,922
+109,111 vol $0.65 each |
109,111 | |
| Filed 2020-05-28 14:47 Tx date 2019-08-02 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Jimenez Jaramillo, Claudia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-21 15:05 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+54,555 vol |
354,555 | |
| Filed 2020-05-21 15:04 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-54,555 vol |
0 | |
| Filed 2020-05-21 15:04 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$35,460
+54,555 vol $0.65 each |
54,555 | |
| Filed 2020-05-21 15:03 Tx date 2019-07-22 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-21 15:01 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+11,538 vol |
461,538 | |
| Filed 2020-05-21 15:01 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-11,538 vol |
0 | |
| Filed 2020-05-21 15:00 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$7,499
+11,538 vol $0.65 each |
11,538 | |
| Filed 2020-05-21 14:59 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-21 14:58 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+50,000 vol |
50,000 | |
| Filed 2020-05-21 14:55 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-21 14:51 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-50,000 vol |
0 | |
| Filed 2020-05-21 14:50 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$32,500
+50,000 vol $0.65 each |
50,000 | |
| Filed 2020-05-21 14:49 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-21 14:47 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+40,385 vol |
265,385 | |
| Filed 2020-05-21 14:46 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-40,385 vol |
0 | |
| Filed 2020-05-21 14:45 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$26,250
+40,385 vol $0.65 each |
40,385 | |
| Filed 2020-05-21 14:44 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-21 14:42 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+38,461 vol |
788,461 | |
| Filed 2020-05-21 14:41 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-38,461 vol |
0 | |
| Filed 2020-05-21 14:40 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$24,999
+38,461 vol $0.65 each |
38,461 | |
| Filed 2020-05-21 14:38 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-21 11:54 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+76,923 vol |
101,923 | |
| Filed 2020-05-21 11:53 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-76,923 vol |
0 | |
| Filed 2020-05-21 11:52 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$49,999
+76,923 vol $0.65 each |
76,923 | |
| Filed 2020-05-21 11:50 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-21 11:33 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+100,000 vol |
300,000 | |
| Filed 2020-05-21 11:30 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-100,000 vol |
0 | |
| Filed 2020-05-21 11:29 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$65,000
+100,000 vol $0.65 each |
100,000 | |
| Filed 2020-05-21 11:26 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-21 11:09 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-100,000 vol |
0 | |
| Filed 2020-05-21 11:07 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+100,000 vol |
150,000 | |
| Filed 2020-05-21 11:04 Tx date 2020-05-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
36 - Conversion or exchange
|
-100,000 vol |
||
| Filed 2020-05-21 11:02 Tx date 2020-04-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$65,000
+100,000 vol $0.65 each |
100,000 | |
| Filed 2020-05-21 10:57 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-20 15:13 Tx date 2020-05-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Holder: Jaque Capital Management Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,428,000
-1,700,000 vol $0.84 each |
11,102,500 | |
| Filed 2020-02-20 14:08 Tx date 2020-02-20 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Holder: Jaque Capital Management Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-474,000
-200,000 vol $2.37 each |
12,802,500 | |
| Filed 2020-01-24 11:41 Tx date 2019-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,000,000,000,000
+1,000,000 vol $1,000,000 each |
5,050,000 | |
| Filed 2020-01-24 11:40 Tx date 2019-12-31 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
-1,000,000 vol |
500,000 | |
| Filed 2020-01-07 13:17 Tx date 2020-01-06 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+50,000 vol $0.50 each |
50,000 | |
| Filed 2020-01-07 13:17 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-07 13:15 Tx date 2020-01-06 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-50,000 vol |
1,275,000 | |
| Filed 2019-12-19 14:44 Tx date 2019-12-19 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,000 vol |
20,000 | |
| Filed 2019-12-19 14:42 Tx date 2019-12-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-10,000 vol |
0 | |
| Filed 2019-12-13 12:12 Tx date 2019-12-11 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
450,000 | |
| Filed 2019-12-13 12:11 Tx date 2019-12-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
0 | |
| Filed 2019-11-12 14:45 Tx date 2019-11-05 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+25,000 vol |
412,500 | |
| Filed 2019-11-12 14:44 Tx date 2019-11-05 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-25,000 vol |
37,500 | |
| Filed 2019-11-08 15:41 Tx date 2019-11-05 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+25,000 vol |
62,500 | |
| Filed 2019-10-31 15:32 Tx date 2019-10-09 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,000 vol |
10,000 | |
| Filed 2019-10-28 18:59 Tx date 2019-06-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,000 vol |
||
| Filed 2019-10-29 08:46 Tx date 2019-07-22 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2019-10-29 08:46 Tx date 2019-07-22 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2019-10-28 19:05 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-28 19:04 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-28 18:42 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-28 19:42 Tx date 2019-04-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+75,000 vol |
75,000 | |
| Filed 2019-10-28 19:41 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-28 19:34 Tx date 2019-04-17 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,000 vol |
20,000 | |
| Filed 2019-10-28 19:24 Tx date 2019-05-23 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2019-10-28 19:05 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2019-10-28 19:04 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2019-10-28 18:59 Tx date 2019-06-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,000 vol |
10,000 | |
| Filed 2019-10-28 18:59 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-28 18:58 Tx date 2019-06-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-10,000 vol |
10,000 | |
| Filed 2019-10-28 18:57 Tx date 2018-12-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,000 vol |
20,000 | |
| Filed 2019-10-28 18:57 Tx date 2018-12-18 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,000 vol |
||
| Filed 2019-10-28 18:57 Tx date 2018-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Bache, Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-28 18:52 Tx date 2019-06-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,406,250,000
+37,500 vol $37,500 each |
387,500 | |
| Filed 2019-10-28 18:51 Tx date 2019-06-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
37,500 | |
| Filed 2019-10-28 18:50 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
75,000 | ||
| Filed 2019-10-28 18:50 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-28 18:42 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-28 18:42 Tx date 2019-09-01 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Botero Diaz, Andres Felipe
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2019-10-28 18:36 Tx date 2019-05-24 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2019-10-28 18:36 Tx date 2019-05-24 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
||
| Filed 2019-10-28 18:35 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
25,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
1,275,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+140,000 vol |
140,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
75,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Echavarria Mesa, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Holder: Jaque Capital Management Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+13,002,500 vol |
13,002,500 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Holder: Jaque Capital Management Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
650,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
1,325,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Wile, Anthony
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+100,000 vol |
100,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
1,125,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Urueña Molina, Jose Vicente
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Aristizabal, Gonzalo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
625,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Aristizabal, Gonzalo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2019-01-23 Tx date 2015-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gomez Casas, Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
320,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+25,000 vol |
25,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gomez Casas, Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Luis Carlos
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
100,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Laitinen, R. Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Echavarria Mesa, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-23 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Antunes de Siqueira, Marcelo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
70,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
2,550,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+350,000 vol |
350,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
225,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
125,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
1,500,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+225,000 vol |
225,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+25,000 vol |
25,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
225,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Pellegrini, Matteo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,250,000 vol |
2,250,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Von Koss, Henning
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
125,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+4,050,000 vol |
4,050,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
2,650,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Cock Correa, Federico
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Uribe, Carlos Manuel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
175,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Langelier, Simon
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+750,000 vol |
750,000 | |
| Filed 2019-01-22 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Gordon, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Human, Delon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
400,000 | |
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Human, Delon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
2,600,000 | |
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
||
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,250,000 vol |
2,250,000 | |
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Human, Delon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
||
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+200,000 vol |
200,000 | |
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Human, Delon
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
2,550,000 | |
| Filed 2019-01-21 Tx date 2019-01-15 |
$PCLO
PharmaCielo Ltd. (formerly, AAJ Capital 1 Corp.) |
Attard, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |